Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocytic Lymphoma, Moxetumomab Pasudotox”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT01030536
What this trial is testing

Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
MedImmune LLC 23
Early research (Phase 1)UnknownNCT00457860
What this trial is testing

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Who this might be right for
Leukemia
Cambridge Antibody Technology 50
Testing effectiveness (Phase 2)Ended earlyNCT02227108
What this trial is testing

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Who this might be right for
B-Cell Pediatric ALL
MedImmune LLC 37
Early research (Phase 1)Ended earlyNCT00587457
What this trial is testing

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

Who this might be right for
Leukemia, Lymphoma, Chronic LymphocyticLeukemia, Prolymphocytic Leukemia, SmallLymphocytic Lymphoma, Moxetumomab Pasudotox
MedImmune LLC 11